Addendum on MNTA’s corporate goals: What does the Advancement of corporate strategy item in the table in #msg-49501257 refer to? I think it refers to Congress’ enactment of an FoB law that contains provisions vis-à-vis clinical trials and interchangeability that MNTA lobbied hard to get (#msg-48581353).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”